P Toivanen Selected Research

P Toivanen Research Topics

10	Arthritis (Polyarthritis) 10/2003 - 03/2000
3	Inflammation (Inflammations) 09/2003 - 03/2001
3	Reactive Arthritis (Reiter Disease) 11/2001 - 01/2000
2	Asthma (Bronchial Asthma) 08/2002 - 01/2000
1	Granuloma 07/2001
1	Necrosis 02/2001
1	Infections 02/2000
1	Myocardial Infarction 01/2000
1	Herpes Simplex 01/2000
1	Salmonella Infections (Salmonellosis) 01/2000
1	Yersinia Infections 01/2000

3	Muramidase (Lysozyme)IBA 10/2003 - 03/2001
3	Peptides (Polypeptides)IBA 10/2003 - 07/2001
3	AntigensIBA 09/2003 - 07/2000
2	Lysine (L-Lysine)FDA Link 10/2003 - 07/2001
2	Peptidoglycan (Murein)IBA 10/2003 - 12/2001
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 03/2002 - 02/2001
2	EnzymesIBA 11/2001 - 03/2001
2	AntibodiesIBA 11/2001 - 01/2000
1	Amino Acids FDA Link 10/2003
1	SteroidsIBA 08/2002
1	Immunoglobulin A (IgA)IBA 11/2001
1	Immunoglobulin G (IgG)IBA 11/2001
1	OrnithineIBA 07/2001
1	Bacterial DNAIBA 03/2001
1	CytokinesIBA 02/2001
1	Interleukin-10 (Interleukin 10)IBA 02/2001
1	Interleukin-4 (Interleukin 4)IBA 02/2001
1	Interleukin-1beta (Interleukin 1 beta)IBA 02/2001
1	Anti-Bacterial Agents (Antibiotics)IBA 07/2000
1	Ribosomal DNA (rDNA)IBA 03/2000
1	UreaseIBA 02/2000
1	C-Reactive ProteinIBA 01/2000
1	bactericidal permeability increasing proteinIBA 01/2000
1	PowdersIBA 01/2000
1	Beclomethasone (Beclometasone)FDA Link 01/2000
1	AutoantibodiesIBA 01/2000
1	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 01/2000

3	Intraperitoneal Injections 10/2003 - 03/2000
1	Dry Powder Inhalers 01/2000
1	Nebulizers and Vaporizers (Inhaler) 01/2000